Results 191 to 200 of about 23,298 (234)

Nasal hyperreactivity and inflammation in perennial allergic rhinitis [PDF]

, 1995
Garrelds, I.M. (Ingrid), Veld, C. (Catharina) in 't   +1 more
core  

Molecular Determinant Underlying Selective Coupling of Primary G-Protein by Class A GPCRs. [PDF]

Adv Sci (Weinh)
Shen Q, Tang X, Wen X, Cheng S, Xiao P, Zang SK, Shen DD, Jiang L, Zheng Y, Zhang H, Xu H, Mao C, Zhang M, Hu W, Sun JP, Zhang Y, Chen Z.   +16 more
europepmc   +1 more source

Deciphering Histamine Pathway Networks in the Human Brain: A Multimodal Approach to Cognition and Psychiatric Disorders

Martins D, Veronese M, Wamelen Dv, Shan L, Howes O, Hampshire A, Turkheimer F, Williams SC.   +7 more
europepmc   +1 more source

Functional and phylogenetic analysis of placozoan GPCRs reveal the prebilaterian origin of monoaminergic signalling

Yañez-Guerra LA, Mayorova TD, Guan L, Jékely G, Wijnen H, Senatore A.   +5 more
europepmc   +1 more source

Inhibition of Histamine Release by Histamine controlled by H2 Receptor [PDF]

Nature, 1973
AGENTS which increase the intracellular level of adenosine 3′-5′-monophosphate (cyclic AMP) in human leukocyte preparations such as the catecholamines, methylxanthines and prostaglandins, inhibit the antigen induced, IgE antibody mediated release of histamine from human leukocytes (basophils)1–3.
Elizabeth Gillespie, Lawrence M. Lichtenstein   +1 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

On the mechanism of histamine H2 receptor activation.

Molecular Pharmacology, 1987
The H2 receptor activation mechanism model proposed by Weinstein et al. [Mol. Pharmacol. 12:738-745 (1976)] has been considered for the set of H2 agonists. The energetics of the model proton transfer processes from a proton-donor site to the heterocycle ring of the agonist molecule and from this one to a proton acceptor site have been studied by using ...
F J, Luque, F, Illas, R, Pouplana
openaire   +2 more sources

Histamine H2-receptor antagonists

Baillière's Clinical Gastroenterology, 1988
The first histamine H2-receptor antagonists were developed in the early 1970s, and they have a dominant role in today's management of peptic ulceration. The original regimens using either cimetidine or ranitidine attempted to control acidity across the 24 hours, but more 'modern' regimens use a large single dose of the H2-blocker in the evening, which ...
openaire   +3 more sources

Histamine H2-Receptor Antagonists

Nursing Clinics of North America, 1991
In summary, histamine initiates acid secretion by stimulating the H2 subtype histamine receptor on parietal cells. Cimetidine, rantidine, famotidine, and nizantidine are histamine H2-receptor antagonists that block this action of histamine, reducing gastric acid output and concentration under both basal and stimulated conditions.
openaire   +2 more sources